Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48‐month longitudinal cohort studyKB Sims, Daniel I. Rosenthal, Seymour Packman et al.|Clinical Genetics|2008Cited by 134